Management of Short PR Interval with Symptoms

Initial Diagnostic Differentiation

The presence of delta waves on ECG is crucial in determining whether a patient has Wolff-Parkinson-White syndrome, with a classic triad including PR interval <120 ms, slurred QRS upstroke, and widened QRS >120 ms, representing ventricular pre-excitation via an accessory pathway bypassing the AV node 2
Symptomatic patients with palpitations, shortness of breath, or chest pain and a short PR interval with delta waves have Wolff-Parkinson-White syndrome and require immediate cardiology referral 1

High-risk features requiring urgent intervention include a shortest pre-excited RR interval <250 ms during atrial fibrillation, history of syncope or near-syncope, documented atrial fibrillation with pre-excitation, multiple accessory pathways or posteroseptal location, and accessory pathway refractory period <240 ms 1, 3
Low-risk indicators include intermittent loss of pre-excitation on ambulatory monitoring and abrupt loss of pre-excitation during exercise testing 1

Catheter ablation is the first-line definitive treatment for symptomatic patients with confirmed WPW syndrome, with success rates of 95-98.5% and major complication rates of only 0.1-0.9%, and should be performed at experienced centers 1, 3
Mandatory indications for ablation include symptomatic tachyarrhythmias, history of syncope, documented atrial fibrillation with WPW, and high-risk features identified on electrophysiology study 1, 3

For hemodynamically unstable patients, immediate synchronized DC cardioversion is recommended to prevent progression to ventricular fibrillation 1, 3
For hemodynamically stable patients with regular narrow-complex tachycardia, vagal maneuvers and IV adenosine are recommended as first-line treatments 4
For hemodynamically stable patients with pre-excited atrial fibrillation, IV procainamide is the first-line treatment 1, 3

AV nodal blocking agents, such as digoxin, diltiazem, verapamil, and beta-blockers, are absolutely contraindicated in pre-excited atrial fibrillation due to the risk of accelerating conduction through the accessory pathway and precipitating ventricular fibrillation 1, 3

Symptoms requiring urgent evaluation include syncope or near-syncope, new onset palpitations lasting >30 minutes, chest pain or dyspnea during palpitations, and episodes occurring while driving 1
Diagnostic workup for symptomatic patients should include 12-lead ECG during tachycardia, 24-hour Holter monitoring, exercise ECG, electrophysiology study, and echocardiography to exclude underlying structural disease 1, 4